Safety of over-the-counter inhalers for asthma: Report of the council on scientific affairs

Barry D. Dickinson, Roy D. Altman, Scott D. Deitchman, Hunter C. Champion

Research output: Contribution to journalArticlepeer-review

10 Scopus citations


The occasional use of over-the-counter (OTC) epinephrine inhalers appears to be safe and effective when used according to labeled instruction by individuals with mild, intermittent asthma. However, gross misuse of these products can cause severe adverse reactions, including death. Limited survey data suggest that approximately 20% of individuals using OTC epinephrine inhalers have mild-to-moderate persistent asthma. According to recent consensus guidelines, these individuals should be under a physician's care and receiving corticosteroid therapy. If these products continue to be marketed, labeling should be strengthened to better educate users about appropriate and inappropriate use of OTC epinephrine inhalers intended for patients with mild, intermittent asthma.

Original languageEnglish (US)
Pages (from-to)522-526
Number of pages5
Issue number2
StatePublished - 2000


  • Administration
  • Adrenergic β-agonists
  • Asthma
  • Drugs
  • Epinephrine
  • Inhalation
  • Inhaler
  • Nonprescr iption
  • Over-the-counter
  • Product labeling
  • Safety

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine
  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Safety of over-the-counter inhalers for asthma: Report of the council on scientific affairs'. Together they form a unique fingerprint.

Cite this